Shraddha Patel, Cpa, MBA
About Shraddha Patel, Cpa, MBA
Shraddha Patel, CPA, MBA, is the Associate Director of Finance Worldwide Medical at Bristol Myers Squibb, with over 20 years of experience in finance and accounting.
Title and Current Role
Shraddha Patel holds the title of Associate Director, Finance Worldwide Medical at Bristol Myers Squibb. In this role, she leads day-to-day finance activities and plays a key role in supporting business partners with strategic, financial, and economic decisions.
Professional Experience at Bristol Myers Squibb
Shraddha Patel has accumulated extensive experience at Bristol Myers Squibb. She started as a Principal Financial Analyst and held various managerial roles in treasury accounting, cash management, US finance, and worldwide medical finance. Notably, she served as Manager, Finance Worldwide Medical from 2017 to 2020, and as Manager, US Finance from 2015 to 2017.
Previous Roles and Industry Experience
Before joining Bristol Myers Squibb, Shraddha Patel worked in various accounting roles. She served as a Senior Accountant at Permacel, and as a Staff Accountant at Cohen, Friedman, Dorman & Leen. Prior to these, she worked at Filomeno & Company CPA Firm and The Roberts Agency, Insurance Agent, following her service as an Agent at the State of Connecticut.
Education and Expertise
Shraddha Patel holds a Master of Business Administration (MBA) in Finance from Rutgers Business School. She earned her Bachelor's Degree in Accounting from Central Connecticut State University. Her educational background, coupled with over 20 years of experience in finance and accounting, underpins her specialization in financial reporting, consolidations, financial planning & analysis, budgeting, and forecasting.
Skills and Collaborative Approach
Shraddha Patel is known for her expertise in process improvement and strategic partnership. She effectively collaborates with non-finance business partners to boost performance and execute projects efficiently. Her ability to lead finance functions and provide critical support for strategic decisions makes her a valuable asset to Bristol Myers Squibb.